Colgate-Palmolive (NYSE: CL) director exercises options, sells 4,170 shares
Rhea-AI Filing Summary
Colgate-Palmolive director John T. Cahill reported an option exercise-and-sale on August 6, 2026. He exercised stock options for 4,170 shares of common stock at an exercise price of $71.56 per share and sold 4,170 shares at a weighted average price of $93.3712–$93.39, with part of the proceeds delivered to Colgate-Palmolive to pay the option exercise price. After these transactions, he continues to hold 36,357 shares indirectly through a trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 4,170 shares ($91K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
CAHILL JOHN T
Role
Director
Sold
4,170 shs ($389K)
Approx. gross sale proceeds
$389K
Approx. exercise cost
$298K
Approx. pre-tax spread
$91K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F4 | 4,170 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 4,170 | $71.56 | $298K |
| Sale | Common Stock F2, F3 | 4,170 | $93.3712 | $389K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 28,373 shares (Direct);
Common Stock — 36,357 shares (Indirect, By Trust)
Footnotes (4)
- F1. Exercise of stock options awarded under the issuer's incentive compensation plan.
- F2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
- F3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. Option became exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date.
Key Figures
Options exercised: 4,170 shares
Option exercise price: $71.56 per share
Shares sold: 4,170 shares
+5 more
8 metrics
Options exercised
4,170 shares
Stock Option (Right to Buy) exercised by John T. Cahill on August 6, 2026
Option exercise price
$71.56 per share
Conversion or exercise price for 4,170 underlying shares of common stock
Shares sold
4,170 shares
Common stock sale reported with transaction code S on August 6, 2026
Weighted average sale price
$93.3712 per share
Weighted average price for shares sold in multiple trades ranging from $93.3712 to $93.39
Indirect holdings after transaction
36,357 shares
Common stock held indirectly "By Trust" following the reported transactions
Option expiration date
2027-05-13
Expiration date for the exercised stock option originally granted in 2019
Option grant date
2019-05-13
Grant date for the option that became exercisable in equal annual installments over three years
Transaction date
2026-08-06
Date of the option exercise and related common stock sale
Key Terms
Stock Option (Right to Buy), incentive compensation plan, weighted average price, indirect, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with 4,170 underlying shares"
incentive compensation plan financial
"Exercise of stock options awarded under the issuer's incentive compensation plan."
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
weighted average price financial
"Weighted average price, as these shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
indirect financial
"Common Stock holding entry reported as indirect with ownership type "By Trust""
By Trust financial
"Indirect ownership nature of ownership reported as By Trust for 36,357 shares"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock transactions did Colgate-Palmolive (CL) director John T. Cahill report?
John T. Cahill reported exercising options for 4,170 shares and selling 4,170 shares of Colgate-Palmolive stock on August 6, 2026. The options had a $71.56 exercise price, and a portion of the sale proceeds was used to pay the option exercise price.
What stock options did Cahill exercise in this Colgate-Palmolive (CL) Form 4?
He exercised a Stock Option (Right to Buy) covering 4,170 shares of Colgate-Palmolive common stock at an exercise price of $71.56 per share. The option was granted on May 13, 2019 and was scheduled to become exercisable in equal annual installments over three years.
Was Cahill’s Colgate-Palmolive (CL) stock sale made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked, and no footnote references a trading plan. Based on the provided data, the sale of 4,170 shares on August 6, 2026 is reported without being identified as executed under a Rule 10b5-1 plan.